Tetraphase Pharmaceuticals Inc.

(TTPH) Trade

By |

Profile

Tetraphase Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections. The company's lead product candidate is XERAVA (eravacycline), a synthetic fluorocycline intravenous and IV antibiotic for use as a first-line empiric monotherapy to treat resistant and multidrug-resistant infections, including multidrug-resistant Gram-negative infections.

Contact Information

Website: www.tphase.com
Main Phone: +1 617 715-3600
Address: 480 Arsenal Street
Address 2: Suite 110
State: MA
City / Town: Watertown
Country: USA
Postal Code: 02472

Issuer Information

Exchange: NGS
CEO: Larry Edwards
Employees: 119
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Tetraphase Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections. The company's lead product candidate is XERAVA (eravacycline), a synthetic fluorocycline intravenous and IV antibiotic for use as a first-line empiric monotherapy to treat resistant and multidrug-resistant infections, including multidrug-resistant Gram-negative infections.

Contact Information

Website: www.tphase.com
Main Phone: +1 617 715-3600
Address: 480 Arsenal Street
Address 2: Suite 110
State: MA
City / Town: Watertown
Country: USA
Postal Code: 02472

Issuer Information

Exchange: NGS
CEO: Larry Edwards
Employees: 119
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 2.92 $ -0.13 (-4.26%)
Last Price 2.92 Change $ -0.13 Change % -4.26 Tick N/A
Bid 2.66 Bid Size 100.00 Ask 2.98 Ask Size 200.00
Open 3.11 High 3.24 Low 2.91 Prev Close 3.05
Last Trade Volume 142,797 52 Wk Hi 29.00 52 Wk Low 1.99
Market Cap 8.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 3,015,824.00 EPS (TTM) -29.56 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 10
Number of Buys 0 5
Number of Sells 0 5
Net Activity 0 -8876
Last 10 Buys Shares
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
Steven R. Gullans 1,000
L. Patrick Gage 1,000
Steven R. Gullans 1,000
Last 10 Sell Shares
Jacques Dumas 1,000
Jacques Dumas 1,000
Jacques Dumas 1,000
Jacques Dumas 1,000
Jacques Dumas 1,000
John Thompson 1,000
Guy Macdonald 1,000
David Charles Lubner 1,000
Patrick Taylor Horn 1,000
L. Patrick Gage 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 6.43 6.43 6.43 6.43
Standard Deviation 2.15 2.15 2.15 2.15
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 05/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 5
Moderate Buy 1 1 1 1
Hold 1 1 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.38 1.63